HOME >> BIOLOGY >> NEWS
Toronto General Hospital to be only Canadian site in first-ever genetic study of anorexia nervosa

Toronto, March 6 -Toronto General Hospital researchers have been selected as the only Canadian hospital in the largest genetic study of anorexia nervosa ever conducted.

The National Institute of Mental Health-funded study is a five-year, $10 million (US) project, led by University of Pittsburgh School of Medicine. It brings together 11 groups of researchers from North America and Europe (10 clinical centres and one to analyze data) to find regions of the human genome that contain genes influencing the risk for anorexia. To find these regions, the researchers will recruit families with two or more members, mainly siblings, who have or had anorexia nervosa, and analyze DNA from the participants.

Dr. Allan S. Kaplan, the Loretta Anne Rogers Chair in Eating Disorders, Head of Eating Disorders Program at Toronto General Hospital and Professor of Psychiatry at University of Toronto, and Dr. Blake Woodside, Director of the Inpatient Eating Disorders Program at Toronto General Hospital and Associate Professor of Psychiatry at the University of Toronto will lead the Canadian-based component of the research. "This research project could be an important turning point in our understanding of the underlying genetic vulnerabilities in anorexia nervosa. The study will identify genes that contribute to anorexia nervosa, ultimately improving our ability to detect, prevent and treat this illness," said Dr. Kaplan.

More studies of this kind are needed because eating disorders are complex diseases with both genetic and environmental components. This research will build on recent genetic studies supported by the Price Foundation, a private, European-based foundation. Price Foundation studies have already pointed to four regions of the genome to look for genes affecting susceptibility to anorexia.

As with other diseases such as Alzheimer's and type 2 diabetes, large samples are needed to identify linkage regions and define the genes contributing liabilit
'"/>

Contact: Kim Garwood
kim.garwood@uhn.on.ca
416-340-4800, ext. 6753
University of Toronto
6-Mar-2003


Page: 1 2

Related biology news :

1. COPD is forgotten killer, says University of Toronto professor
2. NPS Pharma and VIMAC Ventures locate at MaRS, a major new research and enterprise center in Toronto
3. University of Toronto scientists light a path for new nerve cells
4. University of Toronto professor turns hemp into auto parts
5. World Congress on Huntingtons Disease to meet in Toronto, August 16-19, 2003
6. Cancer scientists to be honored by AACR during the organizations annual meeting in Toronto
7. University of Toronto professor finds key protein in fight against plant disease
8. University of Toronto researchers get to the heart of heart failure
9. Orgin of mysterious subterranean gases identified, says University of Toronto researcher
10. Movement without senses coded into neurons, says University of Toronto researcher
11. Water quality was issue in ancient Rome, says University of Toronto scholar

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... FRANCISCO (PRWEB) , ... February 04, 2019 , ... ... of a new Explorer™ story which provides insights to help individuals understand how ... to decreased cardiovascular wellness. , After individuals eat foods that contain choline ...
(Date:2/2/2019)... ... February 01, 2019 , ... uBiome, ... Testing Laboratories by A2LA, which establishes requirements for medical laboratories to demonstrate competence ... is already CLIA-licensed as well as College of American Pathologists (CAP)-accredited, a designation ...
(Date:1/24/2019)... ... 23, 2019 , ... rHEALTH LLC, an innovative digital health ... the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. ... This application covers the addition of a length scale to hydrogel microparticles. ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... 15, 2019 , ... Personalized treatment plans may extend life expectancy for early-stage ... new study published in the journal Radiology. , Kidney, or renal, tumors are ... surgical procedure in which the tumor and part of the kidney are removed. However, ...
(Date:1/11/2019)... ... 11, 2019 , ... Drawing on over 22 years of software development expertise, ... EST will explore some of the key lessons that have driven customer satisfaction with ... multiple vendors, and find out how to ensure that you continue to be able ...
(Date:1/10/2019)... (PRWEB) , ... January 08, 2019 , ... VGI Medical ... has become a leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin ... the facet joint by utilizing a unique patented dual geometric design to limit motion ...
(Date:1/7/2019)... ... 07, 2019 , ... Kainos Medicine Inc. today announced that ... code-named "KM-819." KM-819 is an orally active small molecule that is a ... , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to evaluate ...
Breaking Biology Technology:
Cached News: